ArticleJuntendo medical journal2026
Lupoid Cutaneous Leishmaniasis: A Case Report.
Article in Juntendo medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lupoid Cutaneous Leishmaniasis(LCL) is rare type of cutaneous leishmaniasis that clinically and histologically mimics other granulomatous skin conditions like Lupus Vulgaris. This similarity often cause difficulty in diagnosis, especially in endemic areas. Case Presentation: We report a case of a 29-year-old male who presented with isolated plaque on right cheek persisting for 2 years. The lesion was slowly progressive, non-tender and had not responded completely to local therapy. Smear of initial lesion revealed +LD bodies but the recurrent lesion showed no amastigotes on smear. Histopathology report demonstrated tuberculoid granuloma.These findings gave us diagnostic challenge between leishmaniasis and other granulomatous disorders. Based on history, clinical examination and histopathology report our diagnosis was lupoid leishmaniasis. We gave Intramuscular injection of 20mg/kg Meglumine Antimonate (MA) OD for one month. After one month of follow up, we gave Intralesional MA 1-3ml at the base of the lesion 14 times and this resulted in complete cure of patient. Discussion: This case emphasizes the need of including LCL in the differential diagnosis of chronic granulomatous facial lesions, particularly when there is a history of travel to an endemic location. Early detection and precise diagnosis are critical for avoiding misdiagnosis and unneeded anti-tuberculous treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.